European ADRs Fractionally Lower as Pharma, Telecom Stocks See Mixed Fortunes

American depository receipts of European stocks were 0.3% lower at 118.61 on the Bank of New York Mellon Europe ADR Index on Tuesday morning.

Decliners in Continental Europe were led by Nabriva Therapeutics (NBRV), an Austria-based clinical-stage biopharmaceutical company, 4.1% lower, followed by Novartis (NVS), a Swiss company which manufactures healthcare products, 3.7% lower and Telefonaktiebolaget (ERIC), a Sweden-based telecommunications operator, down by 2.0%.

In the UK, GW Pharmaceuticals (GWPH), a biopharmaceutical company, and WPP (WPPGY), a provider of advertising and marketing services, were 1.8% lower, followed by education company Pearson (PSO), down by 1.6% and Royal Bank of Scotland (RBS), 1.1% lower.

Gainers in Continental Europe were led by DBV Technologies (DBVT), a French clinical-stage biopharmaceutical company, 6.7% higher, followed by Orange (ORAN), a French telecommunication services company, up by 5.1% and Oasmia Pharmaceuticals (OASM), a Sweden-based pharmaceutical company, 4.5% higher.

And, in the UK, mining companies Rio Tinto (RIO) and BHP Billiton (BBL) were 3.7% and 1.9% higher, respectively. Telecommunications company BT Group (BT) was up by 2.4% and Amarin (AMRN), a biopharmaceutical company, was 1.8% higher.